PATRICK SPENCE: Open Payments
NPI 1548504624 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 60 payments from 12 companies in 2025. Trend: 2023 $2,834 · 2024 $861 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 25 | $633 |
| ViiV Healthcare Company | 14 | $416 |
| ABBVIE INC. | 5 | $85 |
| Exact Sciences Corporation | 3 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Napo Pharmaceuticals Inc | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: CABENUVA, APRETUDE, Yeztugo, DOVATO, VRAYLAR, Cologuard Collection Kit, Kerendia, MOUNJARO.
Industry payments across OH — which companies pay providers there.
